Norway· NO-ID_DFB80AB0-C756-42D1-B9AD-606C7409E897
Defitelio
A defibrotide product containing defibrotide, registered in Norway by Gentium S.r.l.. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Defibrotide is registered in 15 of 19 countries.
Countries holding a registration under ATC B01AX01 (defibrotide), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Defibrotide · ATC B01AX01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Defibrotide
- Manufacturer
- Gentium S.r.l.
- Country
- Norway (NO)
- ATC code
- B01AX01
- ATC class
- Defibrotide
- Defined daily dose
- 1.75 g, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_DFB80AB0-C756-42D1-B9AD-606C7409E897
- no_varenummer03520310 x 2.5NOK 49356.5
- gtin7046260352032
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
136 interactions on record for defibrotide.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Defibrotide · interactions on record
136 records
- 71 severe
- 65 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Defibrotide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumDefitelio 80 mg/mlGentium
- SwitzerlandDefitelio 80 mg/ml, Konzentrat zur Herstellung einer InfusionslösungJazz Pharmaceuticals Switzerland GmbH
- CzechiaDEFITELIOGentium S.r.l., Villla Guardia, Como
- FinlandDefitelioGentium S.r.l.
- IrelandDefitelio 80 mg/mL concentrate for solution for infusionGentium S.p.A.
- IcelandDefitelioGentium S.r.l.
- PolandDefitelioGentium S.r.l.
- SwedenDefitelio 80 mg/ml Koncentrat till infusionsvätska, lösningGentium S.r.l.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Defitelio
- Liechtenstein · Defitelio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5ab39298-dc3a-4b6b-b838-7c8aa8c49a5a GET /v1/drugs/5ab39298-dc3a-4b6b-b838-7c8aa8c49a5a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Defibrotid",
"merkevare_id": "ID_DFB80AB0-C756-42D1-B9AD-606C7409E897",
"name_form_strength": "Defitelio kons til inf oppl 80 mg/ml",
"prescription_group": "C"
}See everything about defibrotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.